Split History
PSTI split history picture
Pluristem Therapeutics (PSTI) has 4 splits in our PSTI split history database. The first split for PSTI took place on June 01, 1995. This was a 2 for 1 split, meaning for each share of PSTI owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. PSTI's second split took place on November 24, 1999. This was a 1 for 3 reverse split, meaning for each 3 shares of PSTI owned pre-split, the shareholder now owned 1 share. For example, a 2000 share position pre-split, became a 666.666666666667 share position following the split. PSTI's third split took place on November 26, 2007. This was a 1 for 200 reverse split, meaning for each 200 shares of PSTI owned pre-split, the shareholder now owned 1 share. For example, a 666.666666666667 share position pre-split, became a 3.33333333333333 share position following the split. PSTI's 4th split took place on July 25, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of PSTI owned pre-split, the shareholder now owned 1 share. For example, a 3.33333333333333 share position pre-split, became a 0.333333333333333 share position following the split.

When a company such as Pluristem Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as Pluristem Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the PSTI split history from start to finish, an original position size of 1000 shares would have turned into 0.333333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pluristem Therapeutics shares, starting with a $10,000 purchase of PSTI, presented on a split-history-adjusted basis factoring in the complete PSTI split history. PSTI split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/30/2012
End date: 05/27/2022
Start price/share: $24.30
End price/share: $1.50
Dividends collected/share: $0.00
Total return: -93.83%
Average Annual Total Return: -24.31%
Starting investment: $10,000.00
Ending investment: $617.61
Years: 10.00
Pluristem Therapeutics develops placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries and hematologic conditions. Co.'s product candidates include: Placenta expanded (PLX)-peripheral arterial disease, which is used in recovery following surgery for hip fracture, in Acute Respiratory Distress Syndrome associated with COVID-19 and Intermittent Claudication, and used in for the treatment of Steroid-Refractory Chronic Graft-Versus-Host-Disease; and PLX-R18, which is used in incomplete hematopoietic recovery following hematopoietic cell transplantation and Acute Radiation Syndrome following or before exposure to massive radiation. According to our PSTI split history records, Pluristem Therapeutics has had 4 splits.
Date Ratio
06/01/19952 for 1
11/24/19991 for 3
11/26/20071 for 200
07/25/20191 for 10
PSTI is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

PTIE Split History
PTN Split History
PTX Split History
PULM Split History
PVCT Split History
Q Split History
QGEN Split History
QLTI Split History
RARE Split History
RCKT Split History

Also explore: PSTI shares outstanding history

Email EnvelopeFree PSTI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Blue Hat Interactive Entertainment Technology (BHAT)
Baosheng Media Group Holdings Limited (BAOS)
Salisbury Bancorp, Inc. (SAL)
Global X Cannabis ETF (POTX)
Kinetik Holdings Inc. (KNTK)
China SXT Pharmaceuticals, Inc. (SXTC)
PolarityTE, Inc. (PTE)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Surgalign Holdings, Inc. (SRGA)
Rockwell Medical, Inc. (RMTI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PSTI Insider Buying

PSTI Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.